Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1181, pseudogene (RNU6-1181P) is a non-functional pseudogene derived from the gene encoding U6 small nuclear RNA (snRNA), which is a critical component of the spliceosome—a complex responsible for pre-mRNA splicing in eukaryotic cells[1][3][5]. U6 snRNA pseudogenes are abundant in the human genome and arise through retrotransposition events mediated by Long Interspersed Nuclear Element 1 (LINE-1, or L1) machinery[1][4]. These pseudogenes are typically non-coding and lack the regulatory elements necessary for expression, and they do not participate in known biological pathways or serve as therapeutic targets[4]. While active U6 snRNA has crucial roles in gene expression, the RNU6-1181 pseudogene is a molecular fossil that can serve as a genomic marker for retrotransposition activity but has no direct biological, pathological, or therapeutic functions[4]. Notes: - This entry is not a therapeutic target, druggable molecule, receptor, enzyme, or functional RNA. - The entry is incorrect as a therapeutic target or experimentally actionable molecule, as pseudogenes are generally non-functional and not directly involved in disease mechanisms or drug responses[4]. - No drugs, mechanisms of action, or biomarkers are associated with pseudogenes of U6 snRNA. - Pseudogenes like RNU6-1181P are primarily of evolutionary or genomic interest and may be used as markers for molecular evolutionary studies or to trace the activity of mobile genetic elements in the genome[4]. - For functional U6 snRNA, see "U6 spliceosomal RNA" for relevant molecular and biological details, but these do not apply to the pseudogene forms[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1181, pseudogene (RNU6-1181P).